News Annexon, Inc.

Equities

ANNX

US03589W1027

Real-time Estimate Cboe BZX Other stock markets 15:08:48 03/05/2024 BST			5-day change	1st Jan Change
4.82 ^USD	+3.43%		+3.57%	+7.22%

04-01	JPMorgan Raises Price Target on Annexon to $13 From $11, Maintains Overweight Rating	MT
03-27	Wells Fargo Adjusts Price Target on Annexon to $12 From $11, Maintains Overweight Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting	05-01	GL
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting	05-01	AQ
ANNEXON REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(4)	04-17	AQ
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)	04-16	GL
Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference	04-03	GL
Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference	04-03	AQ
JPMorgan Raises Price Target on Annexon to $13 From $11, Maintains Overweight Rating	04-01	MT
Wells Fargo Adjusts Price Target on Annexon to $12 From $11, Maintains Overweight Rating	03-27	MT
Annexon Q4 Loss Narrows	03-26	MT
Annexon, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-26	CI
Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones	03-26	GL
Annexon, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-26	CI
North American Morning Briefing : Stocks Struggle After New Records	03-22	DJ
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)	03-18	GL
North American Morning Briefing : Inflation Worries Continue to Weigh on Mood	03-15	DJ
North American Morning Briefing : Stock Futures -2-	03-04	DJ
Transcript : Annexon, Inc. - Special Call	03-01
JPMorgan Upgrades Annexon to Overweight From Neutral, Price Target is $11	03-01	MT
Annexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference	02-27	GL
Annexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference	02-27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Annexon, Inc.

Equities

ANNX

US03589W1027

Summary

Filters